Français
Español
English
Portuguese
The Haifa-based company’s Pulsenmore ES system allows pregnant women to perform ultrasound scans from home, with the guidance of a mobile app or remote supervision by a physician.
By Shula Rosen
An Israeli innovation in women’s health is making headlines after the U.S. Food and Drug Administration granted approval for Pulsenmore’s at-home ultrasound device, which allows women to carry out ultrasound monitoring at home.
The Haifa-based company’s Pulsenmore ES system allows pregnant women to perform ultrasound scans from home, with the guidance of a mobile app or remote supervision by a physician.
The approval follows a multicenter clinical study across four major U.S. medical institutions: Mount Sinai Hospital in New York, Brigham and Women’s Hospital in Boston, the University of Florida, and the Fetal Medicine and Women’s Ultrasound Center in Los Angeles.
Researchers found that under medical guidance, women could safely and accurately conduct their own scans, providing doctors with clear imaging for fetal monitoring. The device is expected to play a vital role in expanding access to prenatal care in areas facing physician shortages.
According to the Centers for Disease Control and Prevention, the U.S. records around 3.6 million births annually, with roughly 35 percent of counties classified as “medical deserts” due to limited access to obstetric services. For expectant mothers, especially those with high-risk pregnancies requiring frequent checkups, traveling long distances to clinics can be physically and financially taxing.
Pulsenmore’s technology aims to relieve that burden. Through telemedicine, doctors will be able to remotely assess pregnancy progress, detect potential complications, and reduce the number of in-person visits without compromising care. The company estimates the system could significantly improve monitoring for women in underserved regions.
Because the U.S. already has billing codes for both ultrasound and telehealth services, Pulsenmore’s device can be immediately integrated into the reimbursement system under existing classifications—eliminating the need for new regulatory codes.
Professor Alfred Abuhamed, chairman of Pulsenmore’s U.S. medical advisory board, told The Jerusalem Post that the device is “a game changer,” saying it expands ultrasound accessibility and enables physicians to make real-time medical decisions.
Israeli ultrasound expert Professor Israel Meizner called the technology “a global revolution in fetal monitoring,” noting that it ensures accessible, equitable, and often lifesaving prenatal care. He added that it marks a key step toward more flexible and personalized healthcare for women worldwide. Donate to vital charities that help protect Israeli citizens and inspire millions around the world to support Israel too! Now more than ever, Israel needs your help to fight and win the war -- including on the battlefield of public opinion. Antisemitism, anti-Israel bias and boycotts are out of control. Israel's enemies are inciting terror and violence against innocent Israelis and Jews around the world. Help us fight back!
Do You Love Israel? Make a Donation - Show Your Support!
